A: Yes. Opalora supports eligible patients experiencing weight regain, prolonged plateaus, increased hunger, food noise, or other concerns following sleeve gastrectomy or gastric bypass. Your surgery history, lowest postoperative weight, nutritional status, current symptoms, and previous treatments will be reviewed before recommendations are made.

A: No. Obesity is a chronic condition, and weight regain can occur for many reasons, including appetite changes, metabolic adaptation, hormonal changes, medication effects, stress, sleep disruption, nutritional patterns, or loss of muscle mass. Seeking additional support does not erase your previous progress.

A: No. The program is also designed for eligible patients who have not undergone surgery but want individualized medical support for obesity, insulin resistance, midlife weight changes, persistent plateaus, or other metabolic concerns.

A: GLP-1 and dual-agonist medications may be considered when clinically appropriate. A prescription is never guaranteed and depends on your health history, previous treatment response, contraindications, state of residence, medication availability, and medical evaluation.

A: GLP-1 therapy is not the only treatment option. Depending on your medical history, non-GLP-1 medications, combination strategies, nutrition support, behavioral interventions, and other evidence-based approaches may be considered.

A: Some pathways may include eligible medication, while others cover clinical care and prescription management with medication billed separately. You will receive clear information about inclusions and costs before enrolling.

A: Opalora is a cash-based practice and does not bill insurance directly. Insurance coverage for medication varies by plan and is not guaranteed. A superbill may be available upon request for possible out-of-network reimbursement.

A: Eligible services, laboratory testing, and prescribed treatments may qualify for HSA or FSA payment depending on your plan. Confirm eligibility with your plan administrator.

A: Laboratory testing may be required to evaluate your metabolic health, identify safety concerns, and guide your treatment plan. Recent results may be accepted when clinically appropriate. You will be notified if additional testing is needed.

A: Yes. Visits are completed through secure telehealth for patients who are physically located in a state where Chivas Harris, FNP-C, is licensed at the time of the appointment. (NM, CO, GA, FL, AZ, RI, VT, KS, NV, NJ, NY). More on the way.

A: Follow-up frequency depends on your treatment pathway, medication, and clinical needs. Your schedule will be reviewed before enrollment.

A: Results vary. Your response may be influenced by your medical history, previous bariatric surgery, medication, nutrition, activity, sleep, stress, and consistency with treatment. Opalora does not guarantee a particular amount or rate of weight loss.

A: Potentially. During your evaluation, we will review your current medication, dosage, treatment history, recent laboratory results, and clinical eligibility. Continuing the same medication or dosage cannot be guaranteed until your evaluation is completed.

A: No. Opalora provides specialized medical weight-management support but does not replace your primary care provider, bariatric surgeon, gastroenterologist, or emergency care. Coordination with your established healthcare team may be recommended.